NO140733C - Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme halogenpyrazolderivater - Google Patents

Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme halogenpyrazolderivater

Info

Publication number
NO140733C
NO140733C NO742941A NO742941A NO140733C NO 140733 C NO140733 C NO 140733C NO 742941 A NO742941 A NO 742941A NO 742941 A NO742941 A NO 742941A NO 140733 C NO140733 C NO 140733C
Authority
NO
Norway
Prior art keywords
halogenpyrazole
derivatives
preparation
therapeutically effective
new therapeutically
Prior art date
Application number
NO742941A
Other languages
English (en)
Other versions
NO742941L (no
NO140733B (no
Inventor
Georg Rainer
Richard Riedel
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of NO742941L publication Critical patent/NO742941L/no
Publication of NO140733B publication Critical patent/NO140733B/no
Publication of NO140733C publication Critical patent/NO140733C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO742941A 1973-08-16 1974-08-15 Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme halogenpyrazolderivater NO140733C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU68238A LU68238A1 (no) 1973-08-16 1973-08-16

Publications (3)

Publication Number Publication Date
NO742941L NO742941L (no) 1975-03-17
NO140733B NO140733B (no) 1979-07-23
NO140733C true NO140733C (no) 1979-10-31

Family

ID=19727442

Family Applications (1)

Application Number Title Priority Date Filing Date
NO742941A NO140733C (no) 1973-08-16 1974-08-15 Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme halogenpyrazolderivater

Country Status (18)

Country Link
JP (1) JPS5230515B2 (no)
AT (1) AT339892B (no)
BE (1) BE818912A (no)
CA (1) CA1048499A (no)
CH (1) CH601250A5 (no)
DE (2) DE2462459C3 (no)
DK (1) DK136953B (no)
ES (1) ES429247A1 (no)
FI (1) FI57584C (no)
FR (1) FR2240732B1 (no)
GB (1) GB1475806A (no)
IE (1) IE39999B1 (no)
LU (1) LU68238A1 (no)
NL (1) NL169070C (no)
NO (1) NO140733C (no)
SE (1) SE409454B (no)
YU (1) YU222474A (no)
ZA (1) ZA745252B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5297383A (en) * 1976-02-13 1977-08-16 Ngk Spark Plug Co Ceramic honeycomb structures for exhaust gas purification
HUP0304101A3 (en) * 2003-12-22 2008-10-28 Sanofi Aventis Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates

Also Published As

Publication number Publication date
DE2462459A1 (de) 1977-04-07
JPS5230515B2 (no) 1977-08-09
FI242274A (no) 1975-02-17
ES429247A1 (es) 1976-08-16
IE39999L (en) 1975-02-16
DE2462459B2 (de) 1979-02-08
CH601250A5 (no) 1978-06-30
FI57584B (fi) 1980-05-30
NL7410921A (nl) 1975-02-18
IE39999B1 (en) 1979-02-14
FR2240732A1 (no) 1975-03-14
NO742941L (no) 1975-03-17
GB1475806A (en) 1977-06-10
NO140733B (no) 1979-07-23
AT339892B (de) 1977-11-10
BE818912A (fr) 1975-02-17
DE2438779C3 (de) 1979-09-20
SE409454B (sv) 1979-08-20
DE2438779B2 (de) 1979-01-25
CA1048499A (en) 1979-02-13
DE2462459C3 (de) 1979-10-04
DK136953B (da) 1977-12-19
ATA671174A (de) 1977-03-15
DE2438779A1 (de) 1975-02-27
FI57584C (fi) 1980-09-10
NL169070B (nl) 1982-01-04
LU68238A1 (no) 1975-05-21
FR2240732B1 (no) 1978-07-21
YU222474A (en) 1983-04-27
JPS5049278A (no) 1975-05-01
SE7410419L (no) 1975-02-17
DK136953C (no) 1978-05-29
NL169070C (nl) 1982-06-01
ZA745252B (en) 1976-03-31
DK438174A (no) 1975-04-28

Similar Documents

Publication Publication Date Title
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO138599C (no) Analogifremgangsmaate til fremstilling av nye, terapeutisk virksomme tienopyrimidinderivater
NO140978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO140821C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
NO139386C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive imidazopyridiner
NO140596C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
SE413404B (sv) Forfarande for framstellning av pyrazolderivat
NO140858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 2,4-diamino-5-benzyl-pyrimidinderivater
SE409716B (sv) Analogiforfarande for framstellning av 11beta-alkyl-deltaŸ4-estrener
SE7608956L (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
NO138561C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cykloalkylfenoksykarboksylsyrederivater
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE402106B (sv) Forfarande for framstellning av nya n-(Ÿ-amino)-alkylanilinderivat
NO139125C (no) Analogifremgangsmaate for fremstilling av cykloheksantetrolderivater
NO139961C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzopyranopyridinderivater
SE403112B (sv) Analogiforfarande for framstellning av skopolaminderivat